They will no doubt require SRPT to continue with the trials. The trials are not expected to be completed until 2017 or, more probably, 2018. Without a doubt, SRPT does NOT have the monies to complete such a trial. Therefore, upon news that FDA grants approval, and the stock pops, won't SRPT take that opportunity to do a secondary of millions of new shares???
With such an opinion, one would think you would actually buy a share or two. Though talk is much cheaper, a real concern for someone from Omaha.
The very last panel member even said so. They were voting on the how the study was conducted rather than efficacy alone. Take out the DOUBLE phrase concerning the administration of the study and ONLY ask if the drug was reasonably effective based on ALL the testimony (including that of familys, etc.) and the vote is exact opposite.
I'll go with the hands-on Experts vs. the Sterile Number Crunchers
and here we thought you might actually make your 1st profitable short trade!!! Well, Dumbo, you remain 0-12 in your trades!! You are one Worthless Trader, huh!! ROTFLMAO!!
last time I saw him he was crying uncontrollably, mumbling something about his inability to make a profitable short trade! LOL
and it will be slanted FOR the kids!! The pressure is ON.
Were you a Math Major at your Community college??
the advisory committee hold themselves out as "DMD experts"?? Really???
and how on earth could they recommend approval or disapproval if they don't interpret the "standard" for approval??
You may very well be right!! And on Heavy, heavy volume too!! This is looking like the FDA documents might be quite positive for SRPT.
IF SRPT has received the BDs from FDA as many people claim, don't they have a Legal obligation to release them to public ASAP. Some people say they have received them as long as 1 WEEK ago!!!
While the number of Short shares was increasing at about a 22% clip, the stock price was increasing at an about 30% rate! What does that tell you??
lol You haven't really been an Oracle lately; especially when you were squarely on the side of the fraudulent charities who were supporting BMRN. That had to hurt too, huh?
Glad to help!! Here's another learning moment: Never, ever rely on the advice of a taxi cab driver or an eye doctor for your investment decisions!